Hep C Virus - What's New in Hepatitis C: Current State of the Field and Future

What's New in Hepatitis C: Current State of the Field and Future
Medscape News - The current standard of care for the treatment of previously untreated patients with chronic hepatitis C is a combination of once-weekly injection of pegylated interferon plus daily oral ribavirin. The treatment duration is dependent on HCV genotype

Vertex hepatitis C drug gets fast track
WRGB - (Cambridge, MASS - AP) Vertex Pharmaceuticals has received a "fast track" designation from regulators for a hepatitis C therapy they're developing. The Cambridge-based company's shares rose more than two-percent 56 cents, or 2.2 percent in early